{"id":"https://openalex.org/W2170366015","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0389","title":"Estrogen Receptor \u03b2 (ER\u03b2) Level but Not Its ER\u03b2cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer","display_name":"Estrogen Receptor \u03b2 (ER\u03b2) Level but Not Its ER\u03b2cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer","publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W2170366015","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0389","mag":"2170366015","pmid":"https://pubmed.ncbi.nlm.nih.gov/15355905"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-04-0389","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0389","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-0389","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082220486","display_name":"Majida Esslimani Sahla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Majida Esslimani-Sahla","raw_affiliation_strings":["1Endocrinologie mole\u0301culaire et cellulaire des cancers (U 540), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Montpellier, France; Departments of","2Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Endocrinologie mole\u0301culaire et cellulaire des cancers (U 540), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Montpellier, France; Departments of","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"2Pathology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112420036","display_name":"Jo\u00eblle Simony-Lafontaine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joelle Simony-Lafontaine","raw_affiliation_strings":["2Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Pathology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110270275","display_name":"Andrew Kramar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Kramar","raw_affiliation_strings":["3Biostatistics, Cancer Center Val d\u2019Aurelle, Montpellier, France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Biostatistics, Cancer Center Val d\u2019Aurelle, Montpellier, France; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111992376","display_name":"Roselyne Lavaill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roselyne Lavaill","raw_affiliation_strings":["2Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Pathology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073780219","display_name":"Caroline Moll\u00e9vi","orcid":"https://orcid.org/0000-0003-4827-3684","observed_orcids":["https://orcid.org/0000-0003-4827-3684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Mollevi","raw_affiliation_strings":["3Biostatistics, Cancer Center Val d\u2019Aurelle, Montpellier, France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Biostatistics, Cancer Center Val d\u2019Aurelle, Montpellier, France; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089957002","display_name":"Margaret N. Warner","orcid":"https://orcid.org/0000-0002-7946-2675","observed_orcids":["https://orcid.org/0000-0002-7946-2675"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Margaret Warner","raw_affiliation_strings":["4Department of Medical Nutrition and Biosciences, Karolinska Institute, Novum, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Medical Nutrition and Biosciences, Karolinska Institute, Novum, Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085801141","display_name":"Jan-\u0391\u03ba\u03b5 Gustafsson","orcid":"https://orcid.org/0000-0002-1472-1373","observed_orcids":["https://orcid.org/0000-0002-1472-1373","https://orcid.org/0000-0003-0805-5527"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jan-A\u030ake Gustafsson","raw_affiliation_strings":["4Department of Medical Nutrition and Biosciences, Karolinska Institute, Novum, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Medical Nutrition and Biosciences, Karolinska Institute, Novum, Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034959128","display_name":"Henri Rochefort","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Henri Rochefort","raw_affiliation_strings":["1Endocrinologie mole\u0301culaire et cellulaire des cancers (U 540), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Montpellier, France; Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Endocrinologie mole\u0301culaire et cellulaire des cancers (U 540), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Montpellier, France; Departments of","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.1381,"has_fulltext":false,"cited_by_count":157,"citation_normalized_percentile":{"value":0.97363552,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"10","issue":"17","first_page":"5769","last_page":"5776"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.6601999998092651,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.6601999998092651,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.3359000086784363,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.9710000157356262},{"id":"https://openalex.org/keywords/estrogen-receptor-beta","display_name":"estrogen receptor beta","score":0.8980000019073486},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7350000143051147},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.5889999866485596},{"id":"https://openalex.org/keywords/mib-1-proliferation-index","display_name":"MIB-1 proliferation index","score":0.8169999718666077},{"id":"https://openalex.org/keywords/tumor-size","display_name":"tumor size","score":0.9010000228881836},{"id":"https://openalex.org/keywords/lymph-node-status","display_name":"lymph node status","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8534218072891235},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7618705034255981},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.731442928314209},{"id":"https://openalex.org/C2776067312","wikidata":"https://www.wikidata.org/wiki/Q50429983","display_name":"Antiestrogen","level":5,"score":0.7076989412307739},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5963853597640991},{"id":"https://openalex.org/C4224716","wikidata":"https://www.wikidata.org/wiki/Q10859258","display_name":"Immunostaining","level":3,"score":0.5212981700897217},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5063284635543823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47469061613082886},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4612186849117279},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.43869876861572266},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43568602204322815},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.43177884817123413},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42771580815315247},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.4219355881214142},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38697904348373413},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3569383919239044},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.13454920053482056},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047629","descriptor_name":"Estrogen Receptor beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-04-0389","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0389","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-0389","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:15355905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15355905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W206480088","https://openalex.org/W267005183","https://openalex.org/W378187099","https://openalex.org/W1484694672","https://openalex.org/W1498027545","https://openalex.org/W1500416364","https://openalex.org/W1571431043","https://openalex.org/W1925049844","https://openalex.org/W1973948212","https://openalex.org/W1978282886","https://openalex.org/W1992067336","https://openalex.org/W1995821399","https://openalex.org/W2011619648","https://openalex.org/W2012908746","https://openalex.org/W2020725121","https://openalex.org/W2026637605","https://openalex.org/W2045389096","https://openalex.org/W2058332255","https://openalex.org/W2064482843","https://openalex.org/W2069036217","https://openalex.org/W2069358438","https://openalex.org/W2073883348","https://openalex.org/W2081491080","https://openalex.org/W2100049410","https://openalex.org/W2109388713","https://openalex.org/W2110816122","https://openalex.org/W2113907939","https://openalex.org/W2131437986","https://openalex.org/W2136879986","https://openalex.org/W2138761649","https://openalex.org/W2139365640","https://openalex.org/W2139768136","https://openalex.org/W2153466861","https://openalex.org/W2165866239","https://openalex.org/W2289084246","https://openalex.org/W2321112275","https://openalex.org/W2331269392","https://openalex.org/W4212936275","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2376231494","https://openalex.org/W2104296738","https://openalex.org/W4210794659","https://openalex.org/W2153466861","https://openalex.org/W2362322902","https://openalex.org/W1673285127","https://openalex.org/W2134148782","https://openalex.org/W2040548599","https://openalex.org/W2758307878","https://openalex.org/W2938917047"],"abstract_inverted_index":{"The":[0,72,191],"antiestrogen":[1],"tamoxifen,":[2],"a":[3,102,221],"major":[4],"endocrine":[5],"therapy":[6],"of":[7,20,34,74,80,107,152,159,193,216,259],"estrogen":[8],"receptor":[9],"(ER)-positive":[10],"breast":[11,31],"cancer,":[12],"is":[13,254,279],"nevertheless":[14],"inefficient":[15],"in":[16,88,146,157,163,196],"30":[17],"to":[18,112,289],"40%":[19],"cases":[21],"for":[22],"unknown":[23],"reasons.":[24],"We":[25],"retrospectively":[26],"studied":[27],"50":[28],"ER-positive":[29],"primary":[30],"carcinomas.":[32],"All":[33,106],"the":[35,41,108,188,197,217,228],"patients":[36],"had":[37],"received":[38],"tamoxifen":[39,172,252,291],"as":[40],"only":[42],"adjuvant":[43],"therapy.":[44],"They":[45],"were":[46,110,143,185],"divided":[47],"into":[48],"two":[49,189],"groups":[50],"depending":[51],"on":[52],"whether":[53,156],"they":[54],"relapsed":[55],"within":[56,66],"5":[57,67],"years":[58,68],"(16":[59],"tamoxifen-resistant":[60,147],"cases)":[61],"or":[62,162],"did":[63],"not":[64,271],"relapse":[65],"(34":[69],"tamoxifen-sensitive":[70],"cases).":[71],"expression":[73,180,192,226],"total":[75,153,198],"ER":[76,81,154,177,194,204,224,276,286],"beta":[77,82,178,195,205,225,277],"protein,":[78,84],"and":[79,97,136,181,213,245,267],"cx":[83,179,206],"was":[85,168,200,214,227],"estimated":[86],"anonymously":[87],"formalin-fixed,":[89],"paraffin-embedded":[90],"tumor":[91,131,268],"sections,":[92],"by":[93,115,124,236],"using":[94],"specific":[95],"antibodies":[96],"quantifiying":[98],"nuclear":[99],"immunostaining":[100],"with":[101,171,203,256,272],"computer":[103],"image":[104],"analyzer.":[105],"tumors":[109,261],"found":[111],"be":[113],"HER-2/neu-negative":[114],"immunohistochemistry.":[116],"Univariate":[117],"analysis":[118],"showed":[119],"that":[120],"Scarff-Bloom-Richardsson":[121],"grade":[122,238],"modified":[123],"Elston":[125],"(SBR":[126],"grade;":[127],"P":[128,210,242],"<":[129,211],"0.001),":[130,212,234],"size":[132],"(P":[133,140,174,232,247],"=":[134,141,175,208,233,243,248],"0.042),":[135],"MIB-1":[137,246],"proliferation":[138,265],"index":[139],"0.02)":[142],"significantly":[144],"higher":[145],"tumors.":[148],"A":[149],"low":[150],"level":[151,278],"beta,":[155],"percentage":[158],"positive":[160],"cells":[161],"quantitative":[164],"immunocytochemical":[165],"(QIC)":[166],"score,":[167],"also":[169],"associated":[170,255],"resistance":[173,253],"0.004).":[176],"lymph":[182],"node":[183,273],"status":[184],"similar":[186],"between":[187],"groups.":[190],"population":[199],"positively":[201],"correlated":[202],"(r":[207],"0.63,":[209],"independent":[215,282],"other":[218],"parameters.":[219],"In":[220],"multivariate":[222],"analysis,":[223],"most":[229],"important":[230],"variable":[231],"followed":[235],"SBR":[237,263],"(I+II":[239],"versus":[240],"III;":[241],"0.008),":[244],"0.016).":[249],"To":[250],"conclude,":[251],"classical":[257],"variables":[258],"aggressive":[260],"(high":[262],"grade,":[264],"index,":[266],"size)":[269],"but":[270],"invasiveness.":[274],"Low":[275],"an":[280],"additional":[281],"marker,":[283],"better":[284],"than":[285],"alpha":[287],"level,":[288],"predict":[290],"resistance.":[292]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}